Financial results to be released after
market close;
Conference call to be conducted at 5:00 pm
ET
PHOENIX, May 5, 2022
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report
financial results for its first quarter 2022, ended March 31, 2022, after the market close on
Thursday, May 12, 2022. The Company
has scheduled a conference call that same day, Thursday, May 12, 2022, at 5:00 pm ET, to review the results.
First Quarter 2022 Conference Call Details
Date and Time: Thursday, May 12,
2022, at 5:00 pm ET
Call-in Information: Interested parties can access the
conference call by dialing (844) 308-3351 or (412) 317-5407.
Live Webcast Information: Interested parties can access
the conference call via a live webcast, which is available in the
Investor Relations section of the Company's website at
http://senestech.investorroom.com/.
Replay: A teleconference replay of the call will be
available for seven days at (877) 344-7529 or (412) 317-0088,
replay access code 6656470. A webcast replay will be available in
the Investor Relations section of the Company's website at
http://senestech.investorroom.com/ for 90 days.
About SenesTech
We are "The Pest Control Difference" for the 21st century. We
are rodent fertility control specialists fueled by our passion to
create a healthy environment by virtually eliminating rodent pest
populations. We keep an inescapable truth in mind: 2 rats and their
descendants can be responsible for the birth of up to 15,000 pups
in a year. We invented ContraPest, the only U.S. EPA-registered
contraceptive for male and female rats. ContraPest fits seamlessly
into all integrated pest management programs, greatly improving the
overall goal of effective rat management. We strive for clean
cities, efficient businesses, and happy households – with a product
that was designed to be effective and sustainable without killing
rats. At SenesTech, we don't just eliminate rats. We make a better
world.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement
The foregoing paragraphs contain forward-looking statements that
involve estimates, assumptions, risks and uncertainties. Any
statements about our expectations, beliefs, plans, objectives,
assumptions or future events or performance are not historical
facts and may be forward-looking. "Forward-looking statements" may
be preceded by words such as "may," "future," "plan" or "planned,"
"will," "should," "expected," "anticipates," "continue,"
"eventually," "believes," or "projected." Forward-looking
statements include statements concerning the potential impact and
effects of the COVID-19 pandemic on the Company's business, results
of operations and financial performance; any measures the Company
has and may take in response to COVID-19 and any expectations the
Company may have with respect thereto; the Company's strategy and
target marketing and markets; continuing the Company's vision;
expected benefits of the Company's initiatives and continuation of
those initiatives; deployment of the Company's product; the
continuation or expansion of the use of ContraPest; demand for
ContraPest; the Company's expectation regarding costs, expenses and
cash and continuing its cost improvement plan; future financial
results; and the Company's execution of its strategic business
plan.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-first-quarter-2022-financial-results-on-thursday-may-12-2022-301541125.html
SOURCE SenesTech, Inc.